Evidence map›Paper›PMID 31363079›Full record

ArticleBlood cancer journal2019

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden.

Mina Ali, Konstantinos Lemonakis, Anna-Karin Wihlborg, Ljupco Veskovski, Ingemar Turesson, Ulf-Henrik Mellqvist, Urban Gullberg, Markus Hansson, Björn Nilsson

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mina AliHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.
Konstantinos LemonakisHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.
Anna-Karin WihlborgHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.
Ljupco VeskovskiSection of Hematology, South Elvsborg Hospital, SE 501 83, Borås, Sweden.
Ingemar TuressonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.
Ulf-Henrik MellqvistSection of Hematology, South Elvsborg Hospital, SE 501 83, Borås, Sweden.
Urban GullbergHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.
Markus HanssonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.ORCID http://orcid.org/0000-0002-7715-4548
Björn NilssonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic LociAgedA Kinase Anchor ProteinsAminohydrolasesCell Cycle ProteinsFemaleFormate-Tetrahydrofolate LigaseGenome-Wide Association StudyHumansMaleMethylenetetrahydrofolate Dehydrogenase (NADP)Multienzyme ComplexesMultiple MyelomaPolymorphism, Single NucleotidePrognosisProteinsAKAP12 protein, humanA Kinase Anchor ProteinsAminohydrolasesCell Cycle ProteinsCEP20 protein, humanFormate-Tetrahydrofolate Ligaseformyl-methenyl-methylenetetrahydrofolate synthetaseMethylenetetrahydrofolate Dehydrogenase (NADP)Multienzyme ComplexesProteins

Identifiers

PMID31363079
PMCPMC6667490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.